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Abstract
Background: The aim of this study was to propose a localization strategy for bleeding sites in hemoptysis patients
using their chest computed tomography (CT) findings.
Methods: Between January 2005 and July 2009, the chest CT findings of 161 hemoptysis patients were retrospectively
reviewed. Following chest CT, the lobe with the most prominent ground glass attenuation (GGA) or specific lesions
with the potential to cause pulmonary hemorrhage were analysed to develop a localization strategy for bleeding sites.
Fibre optic bronchoscopy (FOB) findings of active bleeding were used as the standard reference for the bleeding sites.
Results: The concordance rate between the most prominent GGA and FOB findings was higher than that between
specific lesions and FOB findings (Kappa value [k] = 0.751 vs. 0.448, p < 0.001). Among the specific lesions, there were
high concordance rates between lung cancer and FOB findings (3/3, 100%) and fungus balls and FOB findings (8/9,
89%). The agreement of localization of the bleeding site between FOB findings and the localization strategy based on
chest CT findings including the most prominent GGA, lung cancer and fungus balls, showed almost perfect (k = 0.904).
Conclusions: The localization of bleeding sites in hemoptysis patients could be determined by chest CT findings such
as the most prominent GGA, malignancy and fungus ball.
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Background
Massive hemoptysis is one of the most dreaded conditions
among all respiratory emergencies and can have a variety
of underlying causes [1, 2]. Although medical and surgical
treatments have been tried for hemoptysis, the mortality
rate increases significantly to about 40%, when surgery is
undertaken as an emergency procedure [3, 4]. Recently,
bronchial arterial embolism (BAE) has been established as
a fairly effective treatment of choice [5, 6]. Localization of
the specific artery could help to perform successful BAE
and surgery. Therefore, the rapid and exact identification
of the site causing active bleeding is essential for the
successful treatment of patients with hemoptysis. With
technological advances in computed tomography (CT),
chest CT or CT angiography (CTA) is well known as a
comprehensive, non-invasive method for evaluating
hemoptysis patients including for detecting the primary
causes of hemoptysis, determining the site of active bleed-
ing, and planning surgery or BAE [7–10]. Moreover, CT
evaluation is essential when fibre optic bronchoscopy
(FOB) evaluation is difficult, especially in emergencies or
when FOB findings are indeterminate or negative [11–13].
However, localization of bleeding sites using chest CT is
not always easy. Especially in patients with extensive bilat-
eral disease such as multiple sites of bronchiectasis or
equivalent findings, localization of bleeding sites is more
challenging [14]. Furthermore, cases with extensive bilat-
eral or multifocal bronchiectases are more common in
tuberculosis-prevalent areas than in non-prevalent areas,
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as are cases with complicated fungus balls associated with
pre-existing bronchiectasis.
Therefore, the aim of this study was to propose a
localization strategy for bleeding sites based on chest CT
in patients with hemoptysis.
Methods
Patients and study design
We reviewed the medical records of patients with
hemoptysis from January 2005 to July 2009. One hundred
sixty-one patients with hemoptysis who had undergone
chest CT and FOB were enrolled in this study. The
median time interval between chest CT and FOB was
3 days (Interquartile range = 2–5 days).
The definition of massive hemoptysis varies widely
according to different reports and it ranges between 100
and 1000 mL of blood in a 24-h period [15]. It is esti-
mated that more than 100 mL of hemoptysis which can
cause abnormal gas exchange and/or airway obstruction
or hemodynamic instability [15]. So, we defined massive
hemoptysis as more than 100 mL in 24 h.
CT scanning and image analysis
A 64-multidetector CT (MDCT) scanner (Sensation Car-
diac 64; Siemens, Forchheim, Germany) and a 4-MDCT
scanner (LightSpeed Qx/I; GE Medical System, Milwaukee,
Wisconsin) were used to evaluate the thorax and the upper
abdomen from the level of the supraclavicular area to the
level of the upper pole of the right kidney. Ninety-one of
the 161 patients underwent conventional enhanced CT and
71 patients underwent CTA. Pre-enhanced high-resolution
CT (HRCT) preceded conventional enhanced CT or CTA.
All the patients underwent craniocaudal scanning in the
supine position and at end-inspiratory suspension during a
single-breath hold. Two chest radiologists, who were
blinded to the FOB findings and who had more than
10 years’ experience reading thoracic CT scans, analysed
the CT images. Final decisions regarding the findings were
determined in consensus. Bronchial or non-bronchial
systemic arteries identified by CTA were not evaluated in
this study.
We evaluated abnormal radiological findings in the
CT images as follows: First, we evaluated the presence
or absence of ground glass attenuation (GGA), which is
the result of the alveolar lumen filling with blood [7].
Among the lobes with GGA, we defined the site with
the most prominent GGA as the lobe that has the largest
extent or highest attenuation of GGA determined by the
subjective opinion of each radiologist (Fig. 1). We pre-
sumed that the lobe with an active bleeding focus would
have more prominent GGA than the other lobes.
Discrepancies in the assessment were solved by consen-
sus. We also checked for specific lesions that can cause
hemoptysis such as bronchiectasis, active tuberculosis,
old inflammatory lesions, fungus balls, malignancy
and pneumonia. Bronchiectasis was defined as tubular
or cystic bronchiectasis or bronchi twice as large as
the diameter of the neighbouring arteries. Active
tuberculosis was diagnosed when Mycobacterium tu-
berculosis was cultured from sputum or a FOB speci-
men with the typical radiological findings such as a
tree-in-bud appearance [16]. A fungus ball was
defined as a typical intracavitary round mass of soft-
tissue density with an air-crescent sign visible on a
chest CT scan [17]. The diagnosis of old inflamma-
tory lesions caused by previous inflammation such as
tuberculosis infections was based on a combination of
the following findings: calcified granulomas, fibrocica-
tricial retractile linear opacities, bronchiectasis and
pleural thickening [17]. Bronchiectasis with other se-
quelae of previous inflammation was classified as an
old inflammatory lesion. Lung malignancy was desig-
nated as such only when pathological confirmation
had been achieved. Pneumonia was defined according
to the typical radiological finding and appropriate
resolution with antibiotic therapy.
To locate the bleeding site, we compared concordance
between the most prominent GGA and specific lesions.
In the localization strategy for bleeding sites, the lesion
which had a higher concordance with FOB findings was
determined as a bleeding focus.
Categorization of the FOB findings
Only direct visualization of active bleeding was regarded
as a meaningful FOB finding that suggested the location
of the exact bleeding focus. Indirect signs of bleeding
such as hyperaemic mucosa or blood clot on FOB were
also considered negative findings. Then, each result for
predicting the bleeding focus by chest CT was compared
with the FOB findings only in patients with visible active
bleeding on FOB.
Statistical analyses
Statistical analyses were performed with commercially
available software (SPSS version 21.0; IBM Company,
Chicago, Illinois). A bleeding focus on chest CT was
decided by two criteria: the most prominent GGA site
or the site with other abnormal findings that caused
hemoptysis. FOB findings were used as a standard to
determine the lobar localization of the active bleeding
sites. For the evaluation of agreement between each of
the FOB findings and each chest CT finding for the
localization of the bleeding sites, the kappa value
(Cohen’s kappa coefficient, k) was used. The level of
agreement was assessed as follows: k < 0, no agreement;
k = 0.0–0.20, slight agreement; k = 0.21–0.40, fair agree-
ment; k = 0.41–0.60, moderate agreement; k = 0.61–0.80,
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substantial agreement; k = 0.81–1.00, almost perfect
agreement. Statistical significance was set at P < 0.05.
Results
Baseline characteristics
The study included 94 men (58.4%) with a median age of
57.0 years (interquartile range [IQR] = 48.0–68.1 years).
Among all the patients, 51 (31.7%) had massive
hemoptysis (Table 1).
CT findings and the concordance between chest CT and
FOB findings for the localization of bleeding sites
Of all 161 patients, GGA lesions were found in 118
(73.3%); specific lesions, in 125 (77.6%); and combined
GGA and specific lesions, in 89 (55.3%). Seven patients
(4.3%) did not have either GGA or specific lesions in
their chest CT scans. Among patients with GGA lesions
in their chest CT scan, 25 (21.2%) had GGA in a single
lobe and 93 (78.8%) had GGA in multiple lobes. The
median number of lobes with GGA per patient was 2
(IQR = 2–3). In 125 patients with specific lesions on
their chest CT scan, the most common lesion was
bronchiectasis (n = 36, 28.8%) followed by tuberculosis
(n = 31, 24.8%), old inflammatory lesions (n = 30,
24.0%), pneumonia (n = 11, 8.8%), fungus ball (n = 9,
7.2%), malignancy (n = 4, 3.2%) and others (4, 3.2%)
such as paragonimiasis, catamenial hemoptysis, con-
genital cystic adenomatous malformation and broncho-
oesophageal fistula (Table 1).
For the concordance between each lesion and FOB find-
ings, the k-value was significantly higher in the most
prominent GGA sites compared to that in the specific le-
sions sites (0.751 vs. 0.448, p < 0.001). Among 84 patients
with specific lesions who had positive FOB findings for de-
termining bleeding focus, malignancies or fungus balls
(Fig. 2) had a high concordance with the FOB findings (3/
3, 100% for malignancies and 8/9, 89% for fungus balls).
However, old inflammatory lesions (Fig. 3), active tubercu-
losis, bronchiectasis (Fig. 1) and pneumonia revealed low
concordance rates (47, 42, 41 and 33%).
Fig. 1 A 52-year-old woman with hemoptysis and multifocal bronchiectases. a–c Continuous chest computed tomography scans with a lung window
setting show multifocal ground glass attenuations (GGAs, black arrows in a–c) in the lingular segment of the left upper lobe (LUL), the right middle lobe
(RML), and the left lower lobe (LLL) with combined mild bronchiectasis in the RML (white arrow in b) and LLL (white arrow in c). The most prominent GGA
site is the left lower lobe. d Selective left bronchial arteriogram shows tortuous and dilated left bronchial arteries with abnormal parenchymal staining of
contrast media in the LLL
Table 1 Demographic characteristics and etiologies of patients
with hemoptysis
Characteristics (n = 161) Number or %
Age, median (IQR), years 57 (48.0–68.1)
Sex, male 94 (58.4%)
Massive hemoptysis 51 (31.7%)
Etiologies of hemoptysis (n = 125)
Bronchiectasis 36 (28.8%)
Tuberculosis 31 (24.8%)
Old inflammatory lesions 30 (24.0%)
Pneumonia 11 (8.8%)
Fungus ball 9 (7.2%)
Malignancy 4 (3.2%)
Othersa 4 (3.2%)
aparagonimiasis, catamenial hemoptysis, congenital cystic adenomatous
malformation and broncho-esophageal fistula
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Diagnostic strategy for the localization of a bleeding site
using chest CT
Based on the primary results of our study, decisions
were made to localise the bleeding focus using following
criteria: (1) a single fungus ball or malignancy had prior-
ity over their multiple lesions, GGAs and other specific
lesions, (2) if GGAs were present, the most prominent
GGA was given priority over specific lesions excluding a
single fungus ball or malignancy, and (3) in the absence
of GGAs, the bleeding focus was determined by specific
lesions excluding a fungus ball or malignancy (Fig. 4).
In 105 of the 107 patients with positive FOB findings,
bleeding sites could be localised from chest CT using
this diagnostic strategy. Of these 105 patients, 100 pa-
tients had concordance between the CT and FOB
localization. The k-value for the localization of the
bleeding focus between CT and FOB revealed almost
perfect agreement (k = 0.904).
Discussion
This is a large cohort study to suggest a rapid localization
strategy using with CT finings in patients with hemoptysis.
This study directly compared between CT and FOB find-
ings in localization of bleeding sites, and active bleeding
visualization by FOB were defined as standard reference
of the bleeding sites. In this study, bleeding sites could be
determined by the localization strategy using with CT
finings such as the most prominent GGA, lung cancer
and fungus ball.
Massive hemoptysis is associated with a high mortality
rate, and accurate determination of the bleeding focus is
important because many patients need emergency treat-
ments such as surgical resection or BAE [3]. Various
modalities are used for planning an emergency treat-
ment in patients with massive hemoptysis, including
chest radiography, chest CT, conventional angiography
and FOB [9, 10]. They are complementary for the accur-
ate determination of the bleeding sites and successful
treatment to reduce the mortality. In addition to deter-
mining the bleeding focus, accurate analysis of the cause
of the hemoptysis is important for effective care. Many
studies revealed that chest CT could be a better tool for
determining bleeding sites compared to other modalities
in patients with hemoptysis [7, 12, 18–21]. Revel et al.
[7] reported that the recognition rates of the bleeding
sites by chest radiography, chest CT and FOB were 46,
70 and 73%, respectively, in patients with large or
massive hemoptysis. However, all the patients in their
study did not undergo all diagnostic modalities, and
agreements among diagnostic modalities were not
performed. Therefore, their study did not suggest a
localization strategy for bleeding sites. Recently, MDCT
revealed more accurate determination of bleeding sites
in patients with hemoptysis due to precise delineation of
bronchial and non-bronchial systemic arteries [22–24].
Fig. 2 A 53-year-old woman with hemoptysis and a fungus ball. a Chest computed tomography scan showing mild bronchiectases in the right
upper lobe (arrow) without evidence of haemorrhagic aspiration. b and c Axial chest computed tomography scan (b) and coronal reformation
image (c) with a lung window setting showing an approximately 2.1 cm soft tissue nodule with the air-crescent sign (arrow head in c) and perile-
sional ground glass attenuations (arrow) in the superior segment of the left lower lobe (LLL)
Fig. 3 A 53-year-old man with hemoptysis and old inflammatory lesions. a–c Continuous high-resolution computed tomography scans showing old
inflammatory lesions with traction bronchiectases and cicatricial volume loss in both the upper lobes and combined peribronchial consolidations (star
in b) in the apicoposterior segment of the left upper lobe (LUL). Multifocal ground glass attenuations (GGAs, arrows in a–c) are seen in the LUL and
right middle lobe (RML). The most prominent GGA site is the lingular segment of the LUL (arrows in c)
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However, evaluation of bleeding sites in patients with bi-
lateral lung abnormalities could be challenging because bi-
lateral and multifocal bronchial arterial dilatations are also
common [22–24]. Furthermore, the evaluation of each ab-
normal vessel including bronchial arteries is very time
consuming and CTA by multidetector CT is often not
available in emergencies [12]. Therefore, exact determin-
ation of the bleeding site is still difficult especially in pa-
tients with diseases causing bilateral lung abnormalities
including tuberculosis and complications of tuberculosis
such as bronchiectasis and fungus balls. Moreover, it is
more challenging in cases with massive hemoptysis
which can cause multiple haemorrhagic aspiration find-
ings on chest CT. In our study, old inflammatory le-
sions, tuberculosis, bronchiectasis and pneumonia
showed very low concordance rates (below 50%) with
FOB findings due to multi-lobar involvements. How-
ever, the localization strategy in this study using find-
ings of CT scan could accurately detect the bleeding
sites, even in diseases presenting bilateral and multi-
lobar involvements.
Localization of bleeding sites using chest CT findings,
including GGA sites and specific lesions that could
cause hemoptysis, has not been studied previously. Ac-
cording to our study, the most prominent GGA site
could be an important clue for determination of the
bleeding site, especially when there is no specific lesion
which can cause bleeding, and there are multiple lesions
such as multi-lobar involvements of bronchiectasis, tu-
berculosis and old inflammatory lesions. Importantly,
sites with a malignancy or fungus ball coincided with the
active bleeding sites on FOB in most cases. This result
suggests that lesions with malignancy or fungus ball
could be considered as an active bleeding focus.
Our study has some limitations. First, the bleeding
sites for all patients could not be defined by FOB. There-
fore, the agreement rates between FOB and chest CT
findings could not be analysed. Since FOB could detect
hemoptysis more effectively in patients with moderate to
severe hemoptysis [2], our findings might have resulted
from these patients. Second, the specific diagnosis was
not confirmed by pathology in all cases. However, all
cases of malignancies and fungus balls were pathologic-
ally confirmed. Third, this was a single centre retro-
spective study, which may limit the generalizability of
our findings to other countries with a different disease
prevalence.
Conclusion
Bleeding sites in hemoptysis patients could be identified
for emergency treatments including surgery and BAE
based on the site of the most prominent GGA, malig-
nancy or fungus ball on chest CT.
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Fig. 4 Localization strategy for bleeding sites in hemoptysis patients. In
computed tomography findings, a single fungus ball or malignancy
were the most probable sites for bleeding and in their absence or
multiple lesions, the most prominent ground glass attenuation (GGA)
was the next probable site. If GGAs did not exist, bleeding sites were
determined using specific lesions other than a fungus ball or malignancy
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